FDA Recalls Covidien Trellis-6 Peripheral Infusion Systems Due to Labeling Error
The FDA is recalling 216 units of the Covidien Trellis-6 Peripheral Infusion System because a manufacturing error caused the balloon inflation ports to be incorrectly labeled.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class I, which indicates a reasonable probability that use of the product will cause serious adverse health consequences or death. The mislabeling of critical ports on a medical device used for infusion presents a significant risk of harm, fitting the criteria for a High severity score.
Plain-English summary
The U.S. Food and Drug Administration (FDA) is recalling 216 units of the Covidien Trellis-6 Peripheral Infusion System. The affected models are BVT608010V01, BVT608030V01, BVT612010V01, and BVT612030V01. These sterile devices are intended for the controlled and selective infusion of physician-specified fluids, including thrombolytics, into the peripheral vasculature.
The recall was initiated due to a manufacturing error that resulted in the risk of incorrect identification of the proximal and distal balloon inflation ports. Specifically, the distal balloon inflation port was incorrectly labeled as proximal, and the proximal balloon port was incorrectly labeled as distal. This labeling error could lead to improper use of the device.
The affected units were distributed worldwide, including nationwide in the United States and in Australia, Canada, Finland, France, Germany, Ireland, Italy, Spain, Sweden, Switzerland, Turkey, and the United Kingdom. A total of 207 units were distributed in the US and 9 units were distributed outside the US. Specific lot numbers for each model are listed in the official recall record. Healthcare providers and facilities should stop using the affected units and contact the manufacturer for instructions on return or replacement.
The recalled product
- Product
- Covidien Trellis-6 Peripheral Infusion System. Models BVT608010V01, BVT608030V01, BVT612010V01, and BVT612030V01. Sterile EO. Product Usage: Intended for controlled and selective infusion of physician-specified fluids, including thrombolytics, into the peripheral vasculature
- Manufacturer
- Covidien
- Category
- Medical Device — Infusion System
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Model BVT608010
- Lot numbers: 9853174
- 9864497
- 9890772
- 9890931
- 9925676
- 9932672
- 9937308
- 9937315
- 9940474
- 9940614
- 9976340
- 9978233
- A001589
- A001740. Model BVT608030
- Lot Numbers: 9853331
- 9887597
- 9887695
- 9887757
- 9932042. Model BVT612010
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Covidien under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Covidien
See all →- HighNellcor bedside SpO2 monitor alarms may not be heard or recognized
FDA (Devices) · 2025-07-30
- SevereCovidien Newport HT70 and HT70Plus Ventilators Capacitor Failure Recall
FDA (Devices) · 2025-06-18
- SevereShiley Adult Tracheostomy Tubes Recalled Due to Flange Disconnection Risk
FDA (Devices) · 2025-04-02
- CriticalMcGrath Mac Video Laryngoscope battery depletion may cause thermal event and explosion
FDA (Devices) · 2024-08-28
- ModerateCovidien McGRATH MAC Video Laryngoscope Instruction Update for Battery Handling
FDA (Devices) · 2024-08-28
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02